About Design Therapeutics, Inc.
https://www.designtx.comDesign Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions.
CEO
Pratik Shah
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 68
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
SR ONE CAPITAL MANAGEMENT, LP
Shares:6.53M
Value:$63.96M
LOGOS GLOBAL MANAGEMENT LP
Shares:3.65M
Value:$35.82M
POINT72 ASSET MANAGEMENT, L.P.
Shares:3.34M
Value:$32.74M
Summary
Showing Top 3 of 159
About Design Therapeutics, Inc.
https://www.designtx.comDesign Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $4.72M ▼ | $-17M ▲ | 0% | $-0.3 ▲ | $-16.84M ▲ |
| Q2-2025 | $0 | $21.42M ▲ | $-19.08M ▼ | 0% | $-0.34 ▼ | $-18.93M ▲ |
| Q1-2025 | $0 | $20.42M ▲ | $-17.71M ▼ | 0% | $-0.31 ▼ | $-20.26M ▼ |
| Q4-2024 | $0 | $16.69M ▲ | $-13.65M ▼ | 0% | $-0.24 ▼ | $-16.55M ▼ |
| Q3-2024 | $0 | $16.25M | $-13.04M | 0% | $-0.23 | $-16.09M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $205.97M ▼ | $211.77M ▼ | $12.05M ▲ | $199.72M ▼ |
| Q2-2025 | $216.28M ▼ | $222.89M ▼ | $9.85M ▲ | $213.04M ▼ |
| Q1-2025 | $229.67M ▼ | $237.47M ▼ | $9.56M ▼ | $227.92M ▼ |
| Q4-2024 | $245.48M ▼ | $252.09M ▼ | $10M ▲ | $242.1M ▼ |
| Q3-2024 | $254.07M | $261.63M | $9.18M | $252.45M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-17M ▲ | $-11.16M ▲ | $6.51M ▼ | $37K ▼ | $-4.62M ▼ | $-11.16M ▲ |
| Q2-2025 | $-19.08M ▼ | $-14.44M ▲ | $20.12M ▲ | $361K ▲ | $6.04M ▲ | $-14.53M ▲ |
| Q1-2025 | $-17.71M ▼ | $-16.79M ▼ | $7.87M ▲ | $23K ▼ | $-8.9M ▼ | $-16.86M ▼ |
| Q4-2024 | $-13.65M ▼ | $-9.86M ▼ | $1.83M ▲ | $263K ▲ | $-7.76M ▲ | $-9.86M ▼ |
| Q3-2024 | $-13.04M | $-9.55M | $-5.83M | $1K | $-15.37M | $-9.53M |
CEO
Pratik Shah
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 68
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
SR ONE CAPITAL MANAGEMENT, LP
Shares:6.53M
Value:$63.96M
LOGOS GLOBAL MANAGEMENT LP
Shares:3.65M
Value:$35.82M
POINT72 ASSET MANAGEMENT, L.P.
Shares:3.34M
Value:$32.74M
Summary
Showing Top 3 of 159